BETA BIONICS INC (BBNX:NASDAQ)
$17.31 0.44 (2.6082%)
Analysed BETA BIONICS INC (BBNX:NASDAQ) News Sources
Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
14-09-2026
yahoo.com
Beta Bionics’ insulin patch pump gets FDA nod
14-09-2026
medtechdive.com
Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
16-09-2026
yahoo.com
Beta Bionics (BBNX) Stock Sees Fair Value Lift As Analysts Reassess Pipeline Timing
16-09-2026
yahoo.com
Beta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains?
17-09-2026
yahoo.com
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock
17-09-2026
yahoo.com
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
22-09-2026
yahoo.com
Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
29-09-2026
yahoo.com
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
29-09-2026
yahoo.com
Beta Bionics (BBNX) Stock Fair Value Rises After Mint Clearance And Analyst Target Changes
09-10-2026
yahoo.com
What is the current price of BETA BIONICS INC (BBNX:NASDAQ)?
The current price of BETA BIONICS INC (BBNX:NASDAQ) is $17.31.
BETA BIONICS INC (BBNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BETA BIONICS INC (BBNX:NASDAQ) since the previous trading day is $0.44.
BETA BIONICS INC (BBNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BETA BIONICS INC (BBNX:NASDAQ) since the previous trading day is 2.6082%.
What is the most recent average sentiment score for BETA BIONICS INC (BBNX:NASDAQ)?
The most recent average sentiment score for BETA BIONICS INC (BBNX:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for BETA BIONICS INC (BBNX:NASDAQ)?
The most recent sentiment for BETA BIONICS INC (BBNX:NASDAQ) is .
SEC-8K** Filing Available For BETA BIONICS INC (BBNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.